시장보고서
상품코드
1739309

인공지능(AI) 의료 진단 앱 시장

Artificial Intelligence Medical Diagnosis App

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 172 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인공지능(AI) 의료 진단 앱 세계 시장은 2030년까지 33억 달러에 달할 전망

2024년에 12억 달러로 추정되는 인공지능(AI) 의료 진단 앱 세계 시장은 2024년부터 2030년까지 CAGR 19.0%로 성장하여 2030년에는 33억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 클라우드 전개는 CAGR 17.1%를 기록하며 분석 기간 종료시에는 21억 달러에 달할 것으로 예측됩니다. 온프레미스 전개 부문의 성장률은 분석 기간 동안 CAGR 22.9%로 추정됩니다.

미국 시장은 추정 3억 610만 달러, 중국은 CAGR 18.0%로 성장 예측

미국의 인공지능(AI) 의료 진단 앱 시장은 2024년에 3억 610만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 18.0%로 성장하여 2030년까지 5억 1,040만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 17.2%와 16.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 14.2%로 성장할 것으로 예측됩니다.

세계 인공지능(AI) 의료 진단 앱 시장 - 주요 동향 및 촉진요인 정리

AI 기반 의료 진단 앱이 디지털 헬스 혁신의 중심이 되는 이유는 무엇일까?

인공지능(AI) 기반 의료 진단 앱은 환자와 임상의에게 직접적이고, 빠르고, 접근이 용이하며, 데이터 기반의 사전 진단을 제공함으로써 진화하는 디지털 헬스케어의 전망에 필수적인 요소로 자리 잡고 있습니다. 이러한 앱은 기계 학습 알고리즘, 이미지 인식, 자연어 처리(NLP), 예측 분석을 사용하여 증상 평가, 의료 데이터 분석, 확률적 진단 및 분류 추천을 생성합니다. 그 유용성은 특히 일차 진료, 피부과, 영상의학과, 안과, 안과, 만성질환 관리에서 질병의 조기 발견을 위한 적시에 인사이트를 제공하고, 불필요한 임상 진료를 줄이며, 원격진료를 지원하는 데에 있습니다.

AI 진단 앱은 사용자가 증상을 해석하고, 치료 경로의 우선순위를 정하고, 적절한 의료 자원을 탐색할 수 있도록 지원함으로써 효율성을 높입니다. 도움을 줌으로써 효율성을 높입니다. 의료 서비스 제공자의 경우, 이러한 도구는 감별 진단을 지원하고, 문서화를 자동화하며, 고위험 사례에 플래그를 지정하여 임상적 의사결정과 업무 처리 능력을 향상시킵니다. 의료비 상승과 의사 부족으로 인해 AI 기반 진단 용도는 일선 의료 서비스를 확장할 수 있는 비용 효율적이고 확장 가능한 방법으로 점점 더 많은 관심을 받고 있습니다.

AI 모델과 의료 데이터 생태계는 어떻게 진단 정확도를 높이고 있는가?

AI 모델 개발과 임상 데이터 생태계와의 통합이 발전함에 따라 의료 진단 앱의 정확성과 사용 편의성이 크게 향상되고 있습니다. 전자 의료 기록(EHR), 이미지 아카이브, 검사 결과, 환자 보고 데이터 등 대규모의 익명화된 데이터세트로 훈련된 지도 학습 알고리즘은 이러한 앱이 질병 패턴을 인식하고, 동반 질환을 식별하고, 질병별 위험 평가를 제공할 수 있도록 합니다. 자연어 처리(NLP) 알고리즘은 자유 텍스트 입력을 해석하고 SNOMED CT 및 ICD-10과 같은 임상 온톨로지를 사용하여 가능성이 높은 상태를 제안하는 증상 검사기 인터페이스에 전원을 공급합니다.

딥러닝과 컨볼루션 신경망(CNN)은 피부과 영상에서 피부암을 검출하고, 망막 스캔으로 당뇨성 망막증을 확인하고, 흉부 엑스레이로 폐렴과 결핵을 분석하는 등 시각적 진단에서 특히 큰 효과를 발휘합니다. 웨어러블 데이터와 센서 데이터를 통합하여 부정맥 감지, 수면 장애, 호흡기 모니터링 등의 분야에서 실시간 진단을 제공하는 앱도 있습니다. 클라우드 기반 플랫폼은 새로운 임상적 증거와 사용자 피드백을 기반으로 실시간 업데이트와 모델 재훈련을 가능하게 하여 앱의 적응성을 높이고 있습니다. 데이터 상호운용성과 연계 학습이 성숙해짐에 따라, 이러한 앱은 더욱 정확하고 설명하기 쉬워졌으며, 임상 검증 기준을 준수하고 있습니다.

시장 수요는 어디에서 가속화되고 있으며, 어떤 사용 사례가 채택을 주도하고 있는가?

AI 기반 의료 진단 앱에 대한 시장 수요는 선진국과 신흥국 시장 모두에서 빠르게 확대되고 있으며, 미국, 유럽, 아시아태평양에서 큰 견인차 역할을 하고 있습니다. 북미에서는 원격의료와의 통합, 높은 스마트폰 보급률, 디지털 치료제 및 AI를 활용한 임상 도구에 대한 높은 규제 모멘텀 등이 확산의 원동력이 되고 있습니다. 유럽에서는 디지털 헬스 개혁과 국영 의료 시스템의 보급으로 AI 진단 앱을 공공 의료 워크플로우에 통합하는 것이 가능해졌습니다. 반면, 아시아태평양에서는 높은 모바일 사용률, 농촌 지역의 제한된 의료 전문가 접근성, 정부 주도의 디지털 헬스 이니셔티브 등으로 인해 도입이 빠르게 진행되고 있습니다.

주요 사용 사례로는 자가 진단을 위한 증상 체크 앱, 콜센터나 챗봇에 사용되는 AI 탑재 선별진료 도우미, 피부과 영상 분석 앱, 안과 검진 앱, 영상의학과 사전 검진 도구 등이 있습니다. 특히 당뇨, 고혈압, 천식 등 만성질환 관리 앱도 생체 정보를 해석하고 실시간 중재를 제안하기 위해 AI를 접목하고 있습니다. 음성이나 표정 분석에 기반한 정신건강 진단은 새로운 영역입니다. 보험사 및 병원 네트워크가 AI 앱을 도입하여 보험금 부정 청구 감소, 페이센트 여정 최적화, 원격 환자 모니터링 프로그램에서의 조기 경고 신호 플래그 설정 등 기업에서의 활용도 확대되고 있습니다.

AI 의료 진단 앱의 세계 성장 원동력은?

AI 의료 진단 앱 시장의 성장은 온디맨드 건강 정보에 대한 소비자 수요 증가, 만성질환의 유병률 증가, AI, 모바일 컴퓨팅, 의료 영상 기술 발전 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 중요한 원동력은 디지털 헬스 플랫폼의 융합, 환자 권한 부여 트렌드, 도시와 미개발 지역 모두에서 진단 격차를 해소할 수 있는 확장 가능한 솔루션의 필요성이며, COVID-19는 원격 진단이 선별, 검사 및 후속 조치에 필수적인 도구라는 것을 입증했습니다. 원격 진단이 선별, 검사, 후속 조치에 필수적인 도구라는 것을 입증하고 보급을 더욱 가속화했습니다.

벤처 자금 조달, 의료 기술 액셀러레이터, AI 스타트업, 의료 기술 기업, 의료 서비스 제공자 간의 전략적 파트너십은 빠른 혁신과 상용화를 촉진하고 있으며, FDA 및 CE와 같은 규제 기관은 임상 등급 AI 앱 승인을 위한 명확한 프레임워크를 제공하고, HIPAA/GDPR을 준수하는 아키텍처는 프라이버시 및 신뢰의 장벽을 해결하고 있습니다. HIPAA/GDPR을 준수하는 아키텍처는 프라이버시와 신뢰의 장벽을 해결하고, EHR과의 통합, 원격의료 플랫폼용 API, 다국어 인터페이스는 이러한 앱을 보다 사용하기 쉽고, 맥락 인식이 가능한 앱으로 만들고 있습니다. AI 진단 툴이 증상 검사기에서 증상별 진단 도우미로 진화함에 따라 중요한 질문이 생깁니다. 인공지능이 탑재된 진단 앱이 안전하고 공정하며 임상적으로 검증된 솔루션을 제공할 수 있을까?

부문

전개(클라우드, 온프레미스), 용도(방사선학, 병리학, 순환기학, 피부과학, 기타 용도), 최종사용자(병원, 진단 센터, 클리닉, 기타 최종사용자)

조사 대상 기업 사례(총 36개사)

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSM 25.06.19

Global Artificial Intelligence Medical Diagnosis App Market to Reach US$3.3 Billion by 2030

The global market for Artificial Intelligence Medical Diagnosis App estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$306.1 Million While China is Forecast to Grow at 18.0% CAGR

The Artificial Intelligence Medical Diagnosis App market in the U.S. is estimated at US$306.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$510.4 Million by the year 2030 trailing a CAGR of 18.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.2% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Global Artificial Intelligence Medical Diagnosis App Market - Key Trends & Drivers Summarized

Why Are AI-Based Medical Diagnosis Apps Becoming Central to Digital Health Transformation?

Artificial Intelligence (AI)-powered medical diagnosis apps are becoming integral to the evolving landscape of digital healthcare by delivering rapid, accessible, and data-driven preliminary diagnostics directly to patients and clinicians. These apps use machine learning algorithms, image recognition, natural language processing (NLP), and predictive analytics to assess symptoms, analyze medical data, and generate probabilistic diagnoses or triage recommendations. Their utility lies in offering timely insights for early disease detection, reducing unnecessary clinical visits, and supporting remote care delivery-especially in primary care, dermatology, radiology, ophthalmology, and chronic disease management.

The global emphasis on patient-centered care, healthcare decentralization, and digital-first medical systems is propelling adoption of these solutions. AI diagnostic apps enhance efficiency by helping users interpret symptoms, prioritize care pathways, and navigate to appropriate healthcare resources. For healthcare providers, these tools assist in differential diagnosis, automate documentation, and flag high-risk cases, thereby improving clinical decision-making and operational throughput. Amid rising healthcare costs and physician shortages, AI-powered diagnostic applications are increasingly viewed as cost-effective, scalable extensions of frontline medical services.

How Are AI Models and Medical Data Ecosystems Enhancing Diagnostic Precision?

Advancements in AI model development and integration with clinical data ecosystems are significantly improving the accuracy and usability of medical diagnosis apps. Supervised learning algorithms trained on large, anonymized datasets-from electronic health records (EHRs), imaging archives, lab results, and patient-reported data-enable these apps to recognize disease patterns, identify comorbidities, and offer condition-specific risk assessments. Natural language processing (NLP) algorithms power symptom-checker interfaces that interpret free-text input and suggest likely conditions using clinical ontologies such as SNOMED CT and ICD-10.

Deep learning and convolutional neural networks (CNNs) are especially impactful in visual diagnostics-such as detecting skin cancer from dermatology images, identifying diabetic retinopathy in retinal scans, or analyzing chest X-rays for pneumonia or tuberculosis. Some apps integrate wearable and sensor data to provide real-time diagnostics in areas like arrhythmia detection, sleep disorders, and respiratory monitoring. Cloud-based platforms are enabling real-time updates and model retraining based on new clinical evidence and user feedback, enhancing app adaptability. As data interoperability and federated learning mature, these apps are becoming more accurate, explainable, and compliant with clinical validation standards.

Where Is Market Demand Accelerating and Which Use Cases Are Leading Adoption?

Market demand for AI-based medical diagnosis apps is growing rapidly in both developed and emerging markets, with significant traction in the U.S., Europe, and Asia-Pacific. In North America, adoption is driven by telemedicine integration, high smartphone penetration, and favorable regulatory momentum toward digital therapeutics and AI-enabled clinical tools. In Europe, digital health reforms and widespread use of national health systems are enabling integration of AI diagnostic apps into public healthcare workflows. Meanwhile, Asia-Pacific is seeing fast adoption due to high mobile usage, limited access to healthcare professionals in rural areas, and government-led digital health initiatives.

Leading use cases include symptom-checker apps for self-assessment, AI-powered triage assistants used in call centers or chatbots, dermatology image analyzers, ophthalmic screening apps, and radiology pre-screening tools. Chronic condition management apps, especially for diabetes, hypertension, and asthma, are also incorporating AI to interpret biometrics and suggest real-time interventions. Mental health diagnostics based on speech and facial expression analytics are an emerging frontier. Enterprise use is also growing, with insurers and hospital networks deploying AI apps to reduce claims fraud, optimize patient journeys, and flag early warning signs in remote patient monitoring programs.

What Is Driving the Global Growth of AI Medical Diagnosis Apps?

The growth in the AI medical diagnosis app market is driven by several key factors, including rising consumer demand for on-demand health information, increasing chronic disease prevalence, and technological advancements in AI, mobile computing, and medical imaging. A critical driver is the convergence of digital health platforms, patient empowerment trends, and the need for scalable solutions to bridge diagnostic gaps in both urban and underserved regions. COVID-19 further accelerated adoption by validating remote diagnostics as essential tools for triaging, testing, and follow-up.

Venture funding, healthtech accelerators, and strategic partnerships between AI startups, medtech firms, and healthcare providers are fueling rapid innovation and commercialization. Regulatory bodies like the FDA and CE are increasingly providing clear frameworks for clinical-grade AI app approval, while HIPAA/GDPR-compliant architectures are addressing privacy and trust barriers. Integration with EHRs, APIs for telehealth platforms, and multilingual interfaces are making these apps more usable and context-aware. As AI diagnostic tools evolve from symptom checkers to condition-specific diagnostic assistants, a key question arises: Can artificial intelligence-powered diagnosis apps deliver safe, equitable, and clinically validated solutions that extend diagnostic intelligence beyond the clinic and into the hands of every user?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence Medical Diagnosis App market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Radiology, Pathology, Cardiology, Dermatology, Other Applications); End-User (Hospitals, Diagnostic Centers, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence Medical Diagnosis App - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Smartphone-Based AI Medical Diagnosis Apps Democratize Access to Early Health Screening
    • Clinical-Grade Algorithms Drive Accuracy of AI Medical Diagnosis Apps in Real-World Settings
    • AI-Powered Apps Expand Telehealth Capabilities With Instant Diagnostic Support
    • Symptom Checkers Integrated With AI Apps Enhance Patient Triage and Navigation
    • Remote Monitoring Features Embedded in AI Diagnosis Apps Improve Chronic Disease Management
    • Regulatory Validation and CE/FDA Approvals Boost Trust in AI-Powered Diagnosis Apps
    • Multi-Language and Voice Recognition Features Improve AI App Accessibility in Diverse Populations
    • Behavioral Health and Dermatology Emerge as Key Focus Areas for AI Medical Diagnosis Apps
    • Real-Time Feedback and Learning Loops Enhance Diagnostic Precision in AI Health Apps
    • Wearable Sync Capabilities Augment Data Streams for AI Diagnosis Applications
    • Consumer Health Ecosystems Evolve Around AI Medical Apps for Proactive Wellness Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence Medical Diagnosis App Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제